BioAdvance News

QR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models

By WebmasterOctober 13, 2011November 1st, 2024No Comments

QR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models
Read more here

Previous PostQR Pharma, Inc. CEO Awarded Iris Newman Women Entrepreneur of the Year
Next PostBioAdvance’s ROI Tops $11 Million